DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




More Industry Headlines

ContextVision unveils AI-powered image enhancement for radiography Altumira aims to remove inconsistencies from DR image reading

AMA survey: Radiologists top users of telemedicine for patient interactions First nationally representative estimates on usage

Sectra showcases work-in-progress, AI functionality at RSNA Gives radiologist greater control over findings

PortaVision unveils new rad and fluoro X-ray systems at RSNA Overcome limitations of C-arm technology

Emory University opens first proton therapy center in Georgia 28th PT center in the U.S.

Scalable AI utilization insights from Montefiore at RSNA Starting with patients at risk for respiratory failure

New VR app may ease MR anxiety Hope to cut down on the need to sedate patients

NYU releases biggest ever MR data set in AI Facebook collaboration With fastMRI, acceleration of imaging by factor of four 'already possible'

Ramsoft partners with QliqSOFT Enables secure messaging of information on mobiles among doctors and patients

Hitachi unveils new CT scanner, Scenaria View 128, at RSNA Provides better workflow with SynergyDrive and large, 80 cm aperture

Dr. Colleen Lawton

ASTRO calls for proton beam therapy coverage

by Lauren Dubinsky , Senior Reporter
The American Society for Radiation Oncology (ASTRO) announced that it is now calling for private insurers and Medicare to provide coverage for proton beam therapy (PBT) in certain circumstances.

ASTRO outlines it in the new Model Policy it issued last week. The radiation oncologists and medical physicists who created it explain that they support PBT coverage for appropriate patients, and also identify the areas of that coverage where there is evidence that development and more research is needed.

Story Continues Below Advertisement

RamSoft PowerServer™ RIS/PACS - Enabling Efficient Diagnostic Imaging

RamSoft's PowerServer™ RIS/PACS is an intuitive, single database application that enables healthcare practices to operate diagnostic imaging more efficiently than ever before.Why is this important? Click to find out.

"It is ASTRO's role to provide our expertise to payers [toward a result] that ensures access to PBT for the appropriate cancer patients," Dr. Colleen A.F. Lawton, chair of ASTRO's board of directors, told DOTmed News.

PBT is a controversial technology due to its cost and that there is not clear evidence that it is more efficacious or offers reduced side-effect when compared to other type of radiotherapy.

The reason why PBT costs significantly more than radiotherapy is because building a proton beam therapy facility comes with a price tag in the neighborhood of $100 million and up. But despite the cost, PBT has been shown to be effective for several pediatric cancers, particularly in the brain, and for some adult cancers, including ocular melanoma.

But research for breast, prostate and lung cancer is still ongoing, and clinical trials supported by the National Cancer Institute are currently gathering patients in all three disease sites at the 14-plus proton therapy treatment centers in the country.

ASTRO is recommending that PBT be covered for the areas in which it has been proven effective, as well as the areas that are still being studied. "We are calling for coverage for patients participating in clinical trials so that we will have the data needed to confirm PBT's effectiveness for other cancers," said Lawton.

But this is not the first time ASTRO has pushed for coverage for PBT. Last September, the society issued its Choosing Wisely list that outlines five things that physicians and patients should question, including not using PBT for prostate cancer unless it is part of a clinical trial.

The society is also calling for the coverage of PBT for patients who have cancers that are difficult to treat, or highly complex or rare cases where the therapy can provide advantages over other treatment options.

Lawton is "extremely hopeful" that insurers and Medicare will accept the Model Policy because ASTRO has developed it to meet existing evidenced-based care. She added that it's very critical that patients are able to participate in clinical trials so that there will be data to validate appropriate treatment.

Back to HCB News
  Pages: 1


You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.